Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-016991
Filing Date
2025-06-12
Accepted
2025-06-12 17:00:00
Documents
1
Period of Report
2025-06-10

Document Format Files

Seq Description Document Type Size
1 form4-06122025_080657.html 4  
1 form4-06122025_080657.xml 4 4470
  Complete submission text file 0001415889-25-016991.txt   5915
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Issuer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ENAVATE SCIENCES 2884 SAND HILL RD., STE 100 MENLO PARK CA 94025
Business Address
Boylan James P (Reporting) CIK: 0001953094 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39580 | Film No.: 251043700